The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Inomed Medizintechnik sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Inomed Medizintechnik is a medical equipment company that designs, develops, and manufactures neuromonitoring devices. The company’s product portfolio includes intraoperative neuromonitoring devices, parathyroid monitoring devices, stereotactic systems, biopsy instruments, and other devices for pain treatment. Its products are used in General surgery, vascular surgery, neurosurgery, orthopedics/spine surgery, functional neurosurgery, diagnostics, and psychiatry. The company has partnerships with various universities and research centers. Inomed is headquartered in Emmendingen, Baden-Wurttemberg, Germany.
The key metrics of Inomed Medizintechnik related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Inomed Medizintechnik is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Inomed Medizintechnik.
For a detailed understanding of the performance of Inomed Medizintechnik, buy the report here.